Altre lingue Zhejiang Medicine Co., Ltd.

Azioni

600216

CNE0000010J2

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
11,4 ^CNY	+0,88%		+3,07%	+6,24%

28/05	La Cina concede l'approvazione della sperimentazione clinica per l'iniezione antibatterica di Zhejiang Medicine	MT
25/04	Zhejiang Medicine Co., Ltd. Riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

China Grants Clinical Trial Approval for Zhejiang Medicine's Antibacterial Injection	28/05
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Zhejiang Medicine Wins Nod to Trial Digestive Acid Drug	28/11
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Zhejiang Medicine Wins Nod to Trial Anti-Tumor Drug	19/09/23
Zhejiang Medicine’s South Korean Unit Clears Good Manufacturing Practice Inspection	23/08/23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25/04/23
Citic Securities says global financial market fluctuations hurt business	31/03/23
Zhejiang Medicine to Market Antibiotic in the US After Getting FDA Nod; Shares Jump 3%	30/01/23
Zhejiang Medicine Co., Ltd.(SHSE:600216) dropped from Shanghai Stock Exchange Health Care Sector Index	09/12/22
Zhejiang Medicine Unit Gets Clinical Trial Approval For Anti-Biliary Tract Cancer Drug	01/11/22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Brokerage CLSA vice-chairman Charles Lin resigns	26/09/22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22
Zhejiang Medicine Co., Ltd.(SHSE:600216) added to Shanghai Stock Exchange Health Care Sector Index	13/06/22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
TaiGen Biopharmaceuticals Turns to Profit in 2021	17/03/22
Zhejiang Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	25/10/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zhejiang Medicine Co., Ltd.

Azioni

600216

CNE0000010J2

Altre lingue

Filtri